Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase.

Infection by the influenza virus remains a global health burden. The approaches utilized here to augment the activity of broadly protective influenza virus antibodies may lead to a new class of immunotherapies with enhanced activity.